IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer

Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer

NCT06918262 ·Status: RECRUITING

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

NCT00233974 ·Status: COMPLETED ·Phase: PHASE2

Sentinel Node Biopsy Vs Observation After Axillary PET

NCT04072653 ·Status: RECRUITING ·Phase: NA

Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer

NCT06149377 ·Status: COMPLETED

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

NCT06559696 ·Status: RECRUITING ·Phase: PHASE3

Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

NCT05326295 ·Status: RECRUITING

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT03381092 ·Status: UNKNOWN

Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery

NCT02617082 ·Status: UNKNOWN

Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer

NCT02651142 ·Status: UNKNOWN ·Phase: NA

Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.

NCT05623280 ·Status: UNKNOWN

Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer

NCT05141630 ·Status: UNKNOWN ·Phase: PHASE2

Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer

NCT04065321 ·Status: RECRUITING

Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer

NCT07154563 ·Status: RECRUITING

Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study

NCT05444647 ·Status: UNKNOWN

Axillary Radiotherapy for Early Stage Breast Cancer With Limited Positive Sentinel Lymph Nodes

NCT02612012 ·Status: UNKNOWN

Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy

NCT01198301 ·Status: COMPLETED

Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China

NCT04076111 ·Status: NOT_YET_RECRUITING

A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases

NCT06544668 ·Status: NOT_YET_RECRUITING

A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China

NCT06591039 ·Status: RECRUITING

Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound

NCT02992769 ·Status: UNKNOWN

Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer

NCT03523299 ·Status: WITHDRAWN ·Phase: NA

Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer

NCT06001528 ·Status: RECRUITING

Ultrasound-based Breast Cancer Screening in Chinese Women

NCT02268643 ·Status: UNKNOWN

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

NCT05441098 ·Status: UNKNOWN

Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT05468710 ·Status: UNKNOWN